China Universal Asset Management Company’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
23,079
+10,052
| +77% | +$439K | 0.09% | 165 |
|
|
2025
Q1 | $357K | Sell |
13,027
-706
| -5% | -$19.3K | 0.03% | 271 |
|
|
2024
Q4 | $552K | Buy |
13,733
+1,311
| +11% | +$52.7K | 0.05% | 241 |
|
|
2024
Q3 | $588K | Buy |
12,422
+5,214
| +72% | +$247K | 0.06% | 199 |
|
|
2024
Q2 | $215K | Sell |
7,208
-4,545
| -39% | -$136K | 0.03% | 230 |
|
|
2024
Q1 | $472K | Buy |
11,753
+5,330
| +83% | +$214K | 0.06% | 187 |
|
|
2023
Q4 | $164K | Buy |
6,423
+5,002
| +352% | +$127K | 0.03% | 222 |
|
|
2023
Q3 | $19.8K | Buy |
1,421
+696
| +96% | +$9.67K | 0.01% | 300 |
|
|
2023
Q2 | $16.7K | Sell |
725
-23
| -3% | -$529 | 0.01% | 283 |
|
|
2023
Q1 | $22.2K | Buy |
748
+191
| +34% | +$5.66K | 0.01% | 206 |
|
|
2022
Q4 | $13.9K | Buy |
557
+72
| +15% | +$1.8K | 0.01% | 201 |
|
|
2022
Q3 | $11K | Buy |
+485
| New | +$11K | ﹤0.01% | 197 |
|